Back
51
Day Range
$271.47
$276.98
52-Week Range
$196.45
$385.22
Volume
203,033
50D / 200D Avg
$329.69
/
$314.04
Prev Close
$274.73
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 102.7 | 0.3 |
| P/B | 6.8 | 2.9 |
| ROE % | 7.5 | 3.7 |
| Net Margin % | 5.4 | 3.8 |
| Rev Growth 5Y % | 46.0 | 10.0 |
| D/E | 0.5 | 0.2 |
Analyst Price Target
Hold
$409.67
+48.6%
Low: $394.00
High: $425.00
Forward P/E
45.2
Forward EPS
$6.08
EPS Growth (est.)
+0.0%
Est. Revenue
6.4 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$19.49
$18.53 – $20.81
|
10 B | 4 |
| FY2029 |
$16.17
$15.38 – $17.26
|
9.3 B | 4 |
| FY2028 |
$12.93
$8.18 – $18.18
|
8.3 B | 10 |
Key Takeaways
Revenue grew 45.99% annually over 5 years — strong growth
Debt/Equity of 0.46 — conservative balance sheet
Generating 941.74M in free cash flow
P/E of 102.67 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.76%
Cash machine — converts 328.21% of earnings into free cash flow
Growth
Revenue Growth (5Y)
45.99%
Revenue (1Y)40.23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
7.46%
ROIC5.27%
Net Margin5.37%
Op. Margin8.37%
Safety
Debt / Equity
0.46
Current Ratio3.41
Interest Coverage7.68
Valuation
P/E Ratio
102.67
P/B Ratio6.75
EV/EBITDA60.19
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 40.23% | Revenue Growth (3Y) | 47.41% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 45.99% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 5.34B | Net Income (TTM) | 286.93M |
| ROE | 7.46% | ROA | 3.50% |
| Gross Margin | 87.49% | Operating Margin | 8.37% |
| Net Margin | 5.37% | Free Cash Flow (TTM) | 941.74M |
| ROIC | 5.27% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.46 | Current Ratio | 3.41 |
| Interest Coverage | 7.68 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 102.67 | P/B Ratio | 6.75 |
| P/S Ratio | 5.51 | PEG Ratio | -0.18 |
| EV/EBITDA | 60.19 | Dividend Yield | 0.00% |
| Market Cap | 29.46B | Enterprise Value | 26.91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 5.34B | 3.81B | 2.46B | 1.42B | 1.18B |
| Net Income | 286.93M | -644.79M | -881.71M | -2.00B | -1.46B |
| EPS (Diluted) | 32.89 | -6.12 | -8.45 | -19.37 | -15.21 |
| Gross Profit | 4.67B | 3.22B | 2.08B | 1.13B | 1.01B |
| Operating Income | 447.14M | -568.20M | -1.21B | -1.79B | -1.44B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.19B | 5.92B | 5.81B | 6.38B | 8.54B |
| Total Liabilities | 3.83B | 2.59B | 2.27B | 2.00B | 2.40B |
| Shareholders' Equity | 4.36B | 3.33B | 3.54B | 4.38B | 6.13B |
| Total Debt | 2.00B | 1.08B | 930.19M | 596.68M | 694.64M |
| Cash & Equivalents | 4.55B | 2.63B | 3.17B | 3.87B | 4.38B |
| Current Assets | 6.23B | 3.99B | 4.20B | 5.21B | 7.61B |
| Current Liabilities | 1.83B | 2.21B | 1.81B | 1.47B | 1.60B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#391 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026